BFlow S.L.

At BFflow, we aim to solve one of the biggest bottlenecks in drug development: the lack of predictive and physiologically relevant preclinical models. We develop organ and vessel-on-a-chip platforms based on advanced microfluidics, designed to better replicate in vivo conditions and improve the reliability of early-stage results.

Our technology enables:

• Fully customized chip design.

• Physiologically relevant microenvironments with controlled geometry and dynamic flow conditions

This means better data, earlier decisions and reduced risk in clinical phases. We are looking to collaborate with pharma, biotech and research groups interested in improving their preclinical models or developing microfluidic solutions.